Incidence of teicoplanin adverse drug reactions among patients with vancomycin-associated adverse drug reactions and its risk factors.
Conclusions: Teicoplanin should be administered with caution and clinicians must consider the risk factors of cross-reaction when prescribing teicoplanin to individuals with a history of vancomycin hypersensitivity.
PMID: 31722513 [PubMed - as supplied by publisher]
Source: The Korean Journal of Internal Medicine - Category: Internal Medicine Authors: Kim BK, Kim JH, Sohn KH, Kim JY, Chang YS, Kim SH Tags: Korean J Intern Med Source Type: research
More News: Allergy | Allergy & Immunology | Drugs & Pharmacology | Internal Medicine | Statistics | Study | Urology & Nephrology